يعرض 1 - 10 نتائج من 65 نتيجة بحث عن '"Mancione, Linda"', وقت الاستعلام: 0.73s تنقيح النتائج
  1. 1
    دورية أكاديمية
    Safety experience with continued exposure to ofatumumab in patients with relapsing forms of multiple sclerosis for up to 3.5 years

    المؤلفون: Hauser, Stephen L, Cross, Anne H, Winthrop, Kevin, Wiendl, Heinz, Nicholas, Jacqueline, Meuth, Sven G, Giacomini, Paul S, Saccà, Francesco, Mancione, Linda, Zielman, Ronald, Bagger, Morten, Gupta, Ayan Das, Häring, Dieter A, Jehl, Valentine, Kieseier, Bernd C, Pingili, Ratnakar, Stoneman, Dee, Su, Wendy, Willi, Roman, Kappos, Ludwig

    المصدر: Multiple Sclerosis Journal. 28(10)

    مصطلحات موضوعية: Biomedical and Clinical Sciences, Clinical Sciences, Clinical Trials and Supportive Activities, Rare Diseases, Patient Safety, Infectious Diseases, Clinical Research, 6.1 Pharmaceuticals, Evaluation of treatments and therapeutic interventions, Antibodies, Monoclonal, Humanized, Humans, Multiple Sclerosis, Multiple Sclerosis, Relapsing-Remitting, Ofatumumab, multiple sclerosis, antibodies, monoclonal, relapsing multiple sclerosis, safety, Neurosciences, Neurology & Neurosurgery, Clinical sciences, Biological psychology

    وصف الملف: application/pdf

    الوصول الحر: https://escholarship.org/uc/item/7tt1r4k0Test

    View record in eScholarship

    أضف إلى المفضلة
  2. 2
    دورية أكاديمية
    COVID-19 Outcomes and Vaccination in People with Relapsing Multiple Sclerosis Treated with Ofatumumab

    المؤلفون: Cross, Anne H, Delgado, Silvia, Habek, Mario, Davydovskaya, Maria, Ward, Brian J, Cree, Bruce AC, Totolyan, Natalia, Pingili, Ratnakar, Mancione, Linda, Hu, Xixi, Sullivan, Roseanne, Su, Wendy, Zielman, Ronald, Gupta, Ayan Das, Montalban, Xavier, Winthrop, Kevin

    المصدر: Neurology and Therapy. 11(2)

    مصطلحات موضوعية: Biomedical and Clinical Sciences, Clinical Sciences, Vaccine Related, Prevention, Cancer, Immunization, Emerging Infectious Diseases, Infectious Diseases, Infection, Good Health and Well Being, ALITHIOS, Anti-CD20 therapy, B-cell therapy, COVID-19, Ofatumumab, Post-marketing, Relapsing multiple sclerosis, SARS-CoV-2, Vaccination, Clinical sciences, Neurosciences

    وصف الملف: application/pdf

    الوصول الحر: https://escholarship.org/uc/item/9p1397t0Test

    View record in eScholarship

    أضف إلى المفضلة
  3. 3
    دورية أكاديمية
    Outcomes of COVID-19 in Ofatumumab-treated Patients with RMS: Data from the ALITHIOS Open-label Extension Study (P1-6.010)

    المؤلفون: Boer, Ibolya, Cree, Bruce, Wiendl, Heinz, Cross, Anne, Delgado, Sylvia, Habek, Mario, Khachanova, Natalia, Ward, Brian, Totolyan, Natalia, Mancione, Linda, Sullivan, Roseanne, Zielman, Ronald, Hu, Xixi, Gupta, Ayan Das, Montalban, Xavier, Winthrop, Kevin

    المصدر: Neurology ; volume 102, issue 17_supplement_1 ; ISSN 0028-3878 1526-632X

    الإتاحة: https://doi.org/10.1212/wnl.0000000000204888Test

    View record in BASE

    أضف إلى المفضلة
  4. 4
    دورية أكاديمية
    COVID-19 Outcomes and Vaccination in People with Relapsing Multiple Sclerosis Treated with Ofatumumab

    المؤلفون: Cross, Anne H., Delgado, Silvia, Habek, Mario, Davydovskaya, Maria, Ward, Brian J., Cree, Bruce A. C, Totolyan, Natalia, Pingili, Ratnakar, Mancione, Linda, Hu, Xixi, Sullivan, Roseanne, Su, Wendy, Zielman, Ronald, Gupta, Ayan Das, Montalban, Xavier, Winthrop, Kevin, Universitat Autònoma de Barcelona. Departament de Medicina

    مصطلحات موضوعية: ALITHIOS, Anti-CD20 THERAPY, B-cell therapy, COVID-19, Ofatumumab, Post-marketing, Relapsing multiple sclerosis, SARS-CoV-2, Vaccination

    وصف الملف: application/pdf

    العلاقة: Neurology and Therapy; Vol. 11 Núm. 2 (june 2022), p. 741-758; Cross, A.H., Delgado, S., Habek, M. et al. Correction to: COVID-19 Outcomes and Vaccination in People with Relapsing Multiple Sclerosis Treated with Ofatumumab. Neurol Ther 11, 759-762 (2022); https://doi.org/10.1007/s40120-022-00346-8Test; https://ddd.uab.cat/record/274987Test; urn:10.1007/s40120-022-00341-z; urn:oai:ddd.uab.cat:274987; urn:scopus_id:85126116412; urn:articleid:21936536v11n2p741; urn:pure_id:319789143; urn:pmid:35284994; urn:pmc-uid:8918079; urn:pmcid:PMC8918079; urn:oai:pubmedcentral.nih.gov:8918079; urn:oai:egreta.uab.cat:publications/8333e1e4-2958-4d20-b098-8a94cf2df045

    الإتاحة: https://doi.org/10.1007/s40120-022-00346-8Test
    https://ddd.uab.cat/record/274987Test

    View record in BASE النص الكامل

    أضف إلى المفضلة
  5. 5
    دورية أكاديمية
    Correction to : COVID-19 Outcomes and Vaccination in People with Relapsing Multiple Sclerosis Treated with Ofatumumab

    المؤلفون: Cross, Anne H., Delgado, Silvia, Habek, Mario, Davydovskaya, Maria, Ward, Brian J., Cree, Bruce A. C, Totolyan, Natalia, Pingili, Ratnakar, Mancione, Linda, Hu, Xixi, Sullivan, Roseanne, Su, Wendy, Zielman, Ronald, Gupta, Ayan Das, Montalban, Xavier, Winthrop, Kevin, Universitat Autònoma de Barcelona. Departament de Medicina

    مصطلحات موضوعية: SDG 3 - Good Health and Well-being, ALITHIOS, Anti-CD20 THERAPY, B-cell therapy, COVID-19, Ofatumumab, Post-marketing, Relapsing multiple sclerosis, SARS-CoV-2, Vaccination

    وصف الملف: application/pdf

    العلاقة: Neurology and Therapy; Vol. 11 Núm. 2 (2022), p. 759-762; Cross, A.H., Delgado, S., Habek, M. et al. COVID-19 Outcomes and Vaccination in People with Relapsing Multiple Sclerosis Treated with Ofatumumab. Neurol Ther 11, 741-758 (2022); https://ddd.uab.cat/record/274987Test; https://ddd.uab.cat/record/274638Test; urn:10.1007/s40120-022-00346-8; urn:oai:ddd.uab.cat:274638; urn:oai:egreta.uab.cat:publications/0796d619-3bd1-4014-9f62-766515c68ffc; urn:pure_id:320940805; urn:pmid:35503396; urn:pmcid:PMC9063620; urn:scopus_id:85129307271; urn:articleid:21936536v11n2p759; urn:pmc-uid:9063620; urn:oai:pubmedcentral.nih.gov:9063620

    الإتاحة: https://ddd.uab.cat/record/274638Test

    View record in BASE النص الكامل

    أضف إلى المفضلة
  6. 6
    sj-docx-11-msj-10.1177_13524585221079731 ��� Supplemental material for Safety experience with continued exposure to ofatumumab in patients with relapsing forms of multiple sclerosis for up to 3.5 years

    المؤلفون: Hauser, Stephen L, Cross, Anne H, Winthrop, Kevin, Wiendl, Heinz, Nicholas, Jacqueline, Meuth, Sven G, Giacomini, Paul S, Sacc��, Francesco, Mancione, Linda, Zielman, Ronald, Bagger, Morten, Das Gupta, Ayan, H��ring, Dieter A, Jehl, Valentine, Kieseier, Bernd C, Pingili, Ratnakar, Stoneman, Dee, Su, Wendy, Willi, Roman, Kappos, Ludwig

    مصطلحات موضوعية: FOS: Clinical medicine, 111702 Aged Health Care, FOS: Health sciences, 110904 Neurology and Neuromuscular Diseases

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::a9255e19de9662f0128568e22c5381caTest


    أضف إلى المفضلة
  7. 7
    sj-docx-6-msj-10.1177_13524585221079731 ��� Supplemental material for Safety experience with continued exposure to ofatumumab in patients with relapsing forms of multiple sclerosis for up to 3.5 years

    المؤلفون: Hauser, Stephen L, Cross, Anne H, Winthrop, Kevin, Wiendl, Heinz, Nicholas, Jacqueline, Meuth, Sven G, Giacomini, Paul S, Sacc��, Francesco, Mancione, Linda, Zielman, Ronald, Bagger, Morten, Das Gupta, Ayan, H��ring, Dieter A, Jehl, Valentine, Kieseier, Bernd C, Pingili, Ratnakar, Stoneman, Dee, Su, Wendy, Willi, Roman, Kappos, Ludwig

    مصطلحات موضوعية: FOS: Clinical medicine, 111702 Aged Health Care, FOS: Health sciences, 110904 Neurology and Neuromuscular Diseases

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::f83f93b240a6aac1d7b6a9a6d1d6f96dTest


    أضف إلى المفضلة
  8. 8
    sj-docx-8-msj-10.1177_13524585221079731 ��� Supplemental material for Safety experience with continued exposure to ofatumumab in patients with relapsing forms of multiple sclerosis for up to 3.5 years

    المؤلفون: Hauser, Stephen L, Cross, Anne H, Winthrop, Kevin, Wiendl, Heinz, Nicholas, Jacqueline, Meuth, Sven G, Giacomini, Paul S, Sacc��, Francesco, Mancione, Linda, Zielman, Ronald, Bagger, Morten, Das Gupta, Ayan, H��ring, Dieter A, Jehl, Valentine, Kieseier, Bernd C, Pingili, Ratnakar, Stoneman, Dee, Su, Wendy, Willi, Roman, Kappos, Ludwig

    مصطلحات موضوعية: FOS: Clinical medicine, 111702 Aged Health Care, FOS: Health sciences, 110904 Neurology and Neuromuscular Diseases

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::e642d9e094f34ce746f69c529ba801c7Test


    أضف إلى المفضلة
  9. 9
    sj-docx-3-msj-10.1177_13524585221079731 ��� Supplemental material for Safety experience with continued exposure to ofatumumab in patients with relapsing forms of multiple sclerosis for up to 3.5 years

    المؤلفون: Hauser, Stephen L, Cross, Anne H, Winthrop, Kevin, Wiendl, Heinz, Nicholas, Jacqueline, Meuth, Sven G, Giacomini, Paul S, Sacc��, Francesco, Mancione, Linda, Zielman, Ronald, Bagger, Morten, Das Gupta, Ayan, H��ring, Dieter A, Jehl, Valentine, Kieseier, Bernd C, Pingili, Ratnakar, Stoneman, Dee, Su, Wendy, Willi, Roman, Kappos, Ludwig

    مصطلحات موضوعية: FOS: Clinical medicine, 111702 Aged Health Care, FOS: Health sciences, 110904 Neurology and Neuromuscular Diseases

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::95e8b452ac24c6130df1a66a04786a79Test


    أضف إلى المفضلة
  10. 10
    sj-docx-5-msj-10.1177_13524585221079731 ��� Supplemental material for Safety experience with continued exposure to ofatumumab in patients with relapsing forms of multiple sclerosis for up to 3.5 years

    المؤلفون: Hauser, Stephen L, Cross, Anne H, Winthrop, Kevin, Wiendl, Heinz, Nicholas, Jacqueline, Meuth, Sven G, Giacomini, Paul S, Sacc��, Francesco, Mancione, Linda, Zielman, Ronald, Bagger, Morten, Das Gupta, Ayan, H��ring, Dieter A, Jehl, Valentine, Kieseier, Bernd C, Pingili, Ratnakar, Stoneman, Dee, Su, Wendy, Willi, Roman, Kappos, Ludwig

    مصطلحات موضوعية: FOS: Clinical medicine, 111702 Aged Health Care, FOS: Health sciences, 110904 Neurology and Neuromuscular Diseases

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::5187a041b328976202c1dc4ae3c1e5dfTest


    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS — أرسل هذا البحث بالبريد الإلكتروني — حفظ البحث